Matches in Nanopublications for { ?s ?p "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP804080.RA87N22FFRKK2BRuvHc3ZGBLBpjUXhUNL8VFNy5aHy5vo130_assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804080.RA87N22FFRKK2BRuvHc3ZGBLBpjUXhUNL8VFNy5aHy5vo130_provenance.
- NP855942.RA5J9DkJS-m9GfQR07RHrgQoMOOHyFO2_x4OHgkaHolS4130_assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855942.RA5J9DkJS-m9GfQR07RHrgQoMOOHyFO2_x4OHgkaHolS4130_provenance.
- NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684906.RAVmsg9OMHhbE3egoaIU673graUtzvQ2opjYqL7YnrJAk130_provenance.
- assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP842621.RAtp4-GUdsDsN7Gr0XPMnTMFRwaPImAQbD2Bd03F195T8130_assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842621.RAtp4-GUdsDsN7Gr0XPMnTMFRwaPImAQbD2Bd03F195T8130_provenance.
- NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_provenance.
- NP645546.RAG8k74TkGdKBXftc-tm8gQBUBOjvMbMtMZp8FTtzh9s4130_assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645546.RAG8k74TkGdKBXftc-tm8gQBUBOjvMbMtMZp8FTtzh9s4130_provenance.